Target intelligence / Profile preview

Olfactory receptor family 6 subfamily Y member 1 (OR6Y1)

Target
OR6Y1
Molecular classification
G protein-coupled receptor, Receptor, Odorant receptor
01

Overview

Olfactory receptor family 6 subfamily Y member 1 (OR6Y1) is a **G protein-coupled receptor (GPCR)** found in humans, encoded by the OR6Y1 gene[1][8]. It belongs to the largest gene family in the human genome, the olfactory receptor family, and is specifically expressed in the olfactory epithelium of the nose, where it detects odorant molecules and triggers neuronal responses that result in the perception of smell[1][4][5][7][8]. OR6Y1, like other olfactory receptors, features a seven-transmembrane domain structure. Its activation by odorants leads to the coupling of intracellular G proteins, which subsequently initiate signal transduction pathways essential for olfactory perception[1][5][6][8]. While olfactory receptors as a class may have roles outside the nose, there is currently no evidence that OR6Y1 is a therapeutic, diagnostic, or pharmacological target[6][7][8]. The nomenclature for olfactory receptors is specific to each organism, and various aliases exist for the same gene due to different naming conventions over time[8].

Other names
Olfactory receptor 6Y1OR6Y1OR6Y2Olfactory receptor 6Y2Olfactory receptor OR1-11OR1-11
02

Mechanism of action

Not applicable (No clinical drugs target this receptor; natural ligands are odorant molecules and signal transduction occurs via G protein activation)[1][5]

03

Biological functions

Detection of chemical stimulus involved in sensory perception of smellSignal transductionG protein-coupled receptor signaling
04

Disease associations

Other (No established role in major disease categories such as cancer, inflammation, infection, etc.; some evidence suggests olfactory receptors, in general, may participate in processes outside olfaction in tissues such as brain, pancreas, and testes, but specific disease roles for OR6Y1 are not documented)[7][6]
05

Safety considerations

None reported (No drugs target this molecule, and no therapeutic safety considerations are documented)[6][8]
06

Interacting drugs

None known (No drugs or therapeutics are documented to selectively target OR6Y1; olfactory receptors are primarily involved in odorant detection and are not current drug targets)[2][6][8]
07

Biomarkers

None known (No evidence for use as a biomarker for patient selection or monitoring)[6][8]

Beyond the preview

Go deeper on Olfactory receptor family 6 subfamily Y member 1 (OR6Y1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Olfactory receptor family 6 subfamily Y member 1 (OR6Y1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call